FDA approves Novo Nordisk's diabetes drug Ozempic in 2 mg dose

 Novo Nordisk said on Monday the U.S. Food and Drug Administration has approved a higher dosage of 2 mg of Ozempic for the treatment of adults with type 2 diabetes.

Ozempic is now approved in the United States in doses of 0.5 mg, 1 mg and 2 mg, the company said. 

https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/U-S-FDA-approves-Novo-Nordisk-s-diabetes-drug-Ozempic-in-2-mg-dose-39890837/